Page Inspect

R&D-Driven and AI-Powered Biopharmaceutical Company | Sanofi

Sanofi

- Our Company
- Our Company
- Our Strategy
- Science with Purpose
- Governance
- Governance
- Board of Directors
- Executive Committee
- Specialist Committees
- Sustainability
- Sustainability
- Sustainable and Equitable Access to Healthcare
- Environmental Impact and Healthcare Systems’ Resilience
- Code of Conduct and Responsible Business
- Diversity, Equity, and Inclusion In and Beyond the Workplace
- Global Health Unit
- Our Legacy
- Our Science
- Our Science
- Our Pipeline
- Therapeutic Areas
- Therapeutic Areas
- Immunology
- Vaccines
- Neurology
- Oncology
- Rare Diseases
- Technology Platforms
- Clinical Trials & Results
- Clinical Trials & Results
- Find a Clinical Trial
- Clinical Study Results
- Investigator Sponsored Studies
- Diversity in Clinical Trials
- External Innovation
- External Innovation
- External Innovation in North America
- External Innovation in Europe
- External Innovation in China
- Digital & AI
- Digital & AI
- Artificial Intelligence in R&D
- Manufacturing and Supply
- Manufacturing and Supply
- Vaccines Manufacturing and Supply
- Patients
- Patients
- Understanding Diseases & Conditions
- Patient Engagement
- Taking Medicines Safely
- Consumer Healthcare (Opella)
- Partnering
- Partnering
- Partnering Focus Areas
- Partnering Focus Areas
- China
- Digital
- General Medicines
- Immunology
- Neuroscience
- Oncology
- Out-Licensing
- Rare Disease
- Technology Platforms
- Vaccines
- Meet the Partnering Team
- Contact Business Development Team

- Media
- Media
- Stories
- Press Releases
- Contacts
- Investors
- Investors
- News and Events
- News and Events
- News
- Upcoming Events
- Past Events
- Shares, ADRs and Bonds
- Shares, ADRs and Bonds
- Share Price
- Dividend
- Shares, Structure and Vote
- Bonds
- Analyst Coverage and Vara Consensus
- Share Repurchases
- American Depositary Receipts
- Financial Reports and Other Publications
- Environment, Social, Governance
- Private Shareholders
- Contacts and Subscription
- Careers

Global

# We chase the miracles of science so you can chase your dreams.
Discover more

## People Stories

#### We’re proud to spotlight those who inspire us to keep going further in the work we do.

### Céline, living with secondary progressive multiple sclerosis

France

Read more

### Xavier, living with autoimmune type 1 diabetes

US

Read more

### Wei, Sanofi

China

Read more

See all stories

## The Power of Chasing A Dream

Every day, we chase the miracles of science to improve people’s lives. We apply our deep understanding of the immune system to develop breakthrough innovations in medicines and vaccines so you can focus on what matters most, chasing your dreams. If you’re chasing your dreams, remember... you’re not alone. **We’re right beside you.**

* * *

## Our Latest Articles

Read our latest articles

Your Health

November 13, 2025

### How ITP Taught Me That My Voice Matters: My Journey from Silence to Advocacy

Read the article

Your Health

November 12, 2025

### Defining a Clearer Path Forward in CIDP: Why Language Matters

Read the article

Your Health

November 12, 2025

### COPD Around the World: The Impact on Patients and Caregivers

Read the article

## About Us

### Who We Are

We are an R&D driven,
AI-powered biopharma company committed to improving people’s lives and creating compelling growth.

Read more

### Our Science

We turn the impossible into possible.

Read more

### Your Health

We chase the miracles of science to improve people’s lives.

Read more

### Our Commitment

We are at the forefront of addressing some of the world's most critical challenges, striving to create a healthier, more resilient future.

Read more

## Our Pipeline

### 5

* * *

Therapeutic areas

### 93

* * *

Compounds in clinical development

### 26

* * *

Clinical trials in phase 3

Explore our pipeline

## Pursue Progress. Discover Extraordinary.

Better is out there. Better medications, better outcomes, better science. It's all down to people like you, from different backgrounds, in different locations, doing different roles. Take the most important step in your career: help us change the lives of people, families and communities for the better.

Explore Career Opportunities

## Our Latest Press Releases

* * *

November 14, 2025

Press Release: Sanofi’s Teizeild recommended for EU approval by the CHMP for patients with stage 2 type 1 diabetes

Read the Press Release

* * *

November 7, 2025

Press Release: ACAAI: Sanofi and Regeneron’s Dupixent pivotal study met all primary and secondary endpoints, reducing signs and symptoms of allergic fungal rhinosinusitis; sBLA accepted for FDA priority review

Read the Press Release

* * *

October 28, 2025

Press release: Sanofi successfully prices USD 3 billion of bond issue

Read the Press Release

* * *

October 24, 2025

Press release: Q3: continued sales and earnings progress

Read the Press Release

* * *

See all press releases

Sanofi

Follow us

-
-
-
-
-
-

Back to top

- Stories
- Contact
- Legal notice
- Privacy & data protection
- Cookies Policy
- Our publications
- Directory
- Sitemap
- Accessibility: partial compliance
- Code of Conduct

© Sanofi 2004-2025 - All rights reserved